.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Julphar
Argus Health
Cipla
AstraZeneca
Daiichi Sankyo
Johnson and Johnson
Farmers Insurance
Queensland Health

Generated: June 24, 2017

DrugPatentWatch Database Preview

ACETAZOLAMIDE SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Acetazolamide Sodium, and when can generic versions of Acetazolamide Sodium launch?

Acetazolamide Sodium is a drug marketed by Hospira, Sagent Agila, X Gen Pharms, West-ward Pharms Int, and Emcure Pharms Ltd. and is included in five NDAs.

The generic ingredient in ACETAZOLAMIDE SODIUM is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

Summary for Tradename: ACETAZOLAMIDE SODIUM

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list3
Bulk Api Vendors: see list69
Clinical Trials: see list2,415
Patent Applications: see list4,121
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ACETAZOLAMIDE SODIUM at DailyMed

Pharmacology for Tradename: ACETAZOLAMIDE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
ACETAZOLAMIDE SODIUM
acetazolamide sodium
INJECTABLE;INJECTION040108-001Oct 30, 1995DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
ACETAZOLAMIDE SODIUM
acetazolamide sodium
INJECTABLE;INJECTION040089-001Feb 28, 1995APRXNoNo► Subscribe► Subscribe
Sagent Agila
ACETAZOLAMIDE SODIUM
acetazolamide sodium
INJECTABLE;INJECTION200880-001May 9, 2012APRXNoNo► Subscribe► Subscribe
X Gen Pharms
ACETAZOLAMIDE SODIUM
acetazolamide sodium
INJECTABLE;INJECTION040784-001Dec 10, 2008APRXNoYes► Subscribe► Subscribe
Emcure Pharms Ltd
ACETAZOLAMIDE SODIUM
acetazolamide sodium
INJECTABLE;INJECTION202693-001Dec 19, 2014APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Novartis
Argus Health
AstraZeneca
Harvard Business School
McKinsey
UBS
Daiichi Sankyo
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot